Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC#

FDA recall notice · announced September 6, 2023 · Contract Pharmaceuticals Limited Canada

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Reason for recall

Defective Container: slow leakage under the cap

Notes

Distribution: Nationwide in the USA.
Lot/code information: Lot # 118920, exp. January 2024.
Quantity: 11,350 bottles
Status: Terminated
Products in this recall event:
- Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceutic (D-1139-2023)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.